Education
About Us
Working with TipRanks
Follow Us
Aclarion, Inc. (ACON)
NASDAQ:ACON
ACON Stock Chart & Stats
Day’s Range― - ―
52-Week Range$6.20 - $3,496.06
Previous Close$0.14
Volume6.36M
Average Volume (3M)13.69K
Market Cap
$4.33M
Enterprise Value-$10.48M
Total Cash (Recent Filing)$14.75M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta1.08
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-8258.72
Shares Outstanding582,371
10 Day Avg. Volume12,333
30 Day Avg. Volume13,685
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)0.10
Price to Sales (P/S)0.00
P/FCF Ratio-0.73
Enterprise Value/Market Cap-2.42
Enterprise Value/Revenue-51.48
Enterprise Value/Gross Profit307.65
Enterprise Value/Ebitda0.48
Forecast
1Y Price Target
$20.00Price Target Upside169.18% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Aclarion, Inc. News
PremiumCompany Announcements
Aclarion, Inc. Holds 2025 Annual Stockholders MeetingPremiumCompany Announcements
Aclarion, Inc. Adjourns Annual Meeting to Solicit Votes
Bulls Say, Bears Say
Bulls Say
Financial StabilityA large war chest raised in Q1 FY25 with over $20 million reduces the need for additional funds through FY25 and FY26.
Market PotentialThe company’s market opportunity in the US is vast, estimated at over $400 million per year.
Product AdoptionNociscan is gaining traction with US healthcare providers, building substantial momentum with new commercial agreements.
Bears Say
Financial PerformanceQ1 FY25 net profit fell below forecast due to a non-operating charge.
Options Prices
Currently, No data available
---
Ownership Overview
9.90%
Insiders
5.71%
Mutual Funds
<0.01% Other Institutional Investors
90.10% Public Companies and Individual Investors
ACON FAQ
What was Aclarion, Inc.’s price range in the past 12 months?
Aclarion, Inc. lowest stock price was $6.20 and its highest was $3496.06 in the past 12 months.
What is Aclarion, Inc.’s market cap?
Aclarion, Inc.’s market cap is $4.33M.
When is Aclarion, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Aclarion, Inc.’s earnings last quarter?
Currently, no data Available
Is Aclarion, Inc. overvalued?
According to Wall Street analysts Aclarion, Inc.’s price is currently Undervalued.
Does Aclarion, Inc. pay dividends?
Aclarion, Inc. does not currently pay dividends.
What is Aclarion, Inc.’s EPS estimate?
Aclarion, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Aclarion, Inc. have?
Aclarion, Inc. has 582,371 shares outstanding.
What happened to Aclarion, Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Aclarion, Inc.?
Currently, no hedge funds are holding shares in ACON
Company Description
Aclarion, Inc.
Aclarion, Inc., a healthcare technology company, develops software application for magnetic resonance spectroscopy (MRS) in the United States. It offers NOCISCAN-LS Post-Processor suite comprising NOCICALC-LS that receives and processes the acquired disc MRS data to calculate levels of degenerative pain biomarkers; and NOCIGRAM-LS, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was founded in 2008 and is based in San Mateo, California.
ACON Stock 12 Month Forecast
Average Price Target
$20.00
▲(169.18%Upside)
Technical Analysis
Streamline Health Solutions
―
Ontrak
―
SCWorx
―
Scienture Holdings
―
Healthcare Triangle
―